Xinlu Fu

468 total citations
12 papers, 374 citations indexed

About

Xinlu Fu is a scholar working on Molecular Biology, Complementary and alternative medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Xinlu Fu has authored 12 papers receiving a total of 374 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Complementary and alternative medicine and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Xinlu Fu's work include Natural Compounds in Disease Treatment (3 papers), Drug-Induced Hepatotoxicity and Protection (2 papers) and Cell death mechanisms and regulation (2 papers). Xinlu Fu is often cited by papers focused on Natural Compounds in Disease Treatment (3 papers), Drug-Induced Hepatotoxicity and Protection (2 papers) and Cell death mechanisms and regulation (2 papers). Xinlu Fu collaborates with scholars based in China. Xinlu Fu's co-authors include Zhiying Huang, Min Huang, Yuwen Qiu, Wenwen Wang, Feihai Shen, Zhongxiang Zhao, Jing Jin, Jing Jin, Jia Li and Xi Chen and has published in prestigious journals such as Nature Communications, PLoS ONE and Life Sciences.

In The Last Decade

Xinlu Fu

12 papers receiving 371 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xinlu Fu China 8 163 127 83 39 32 12 374
Zhenqiang You China 11 187 1.1× 68 0.5× 51 0.6× 17 0.4× 33 1.0× 19 379
Xinjun Cai China 12 181 1.1× 50 0.4× 49 0.6× 33 0.8× 51 1.6× 44 414
Yajie Xiao China 11 118 0.7× 66 0.5× 48 0.6× 26 0.7× 97 3.0× 41 345
Feng‐Juan Han China 13 189 1.2× 53 0.4× 38 0.5× 41 1.1× 41 1.3× 45 550
Mohammadreza Safdari Iran 10 130 0.8× 68 0.5× 30 0.4× 49 1.3× 25 0.8× 20 441
Qianbin Sun China 12 169 1.0× 42 0.3× 30 0.4× 35 0.9× 63 2.0× 15 341
Quan Wang China 8 176 1.1× 41 0.3× 35 0.4× 43 1.1× 17 0.5× 32 387
Xiaowen Bao China 10 166 1.0× 35 0.3× 26 0.3× 33 0.8× 24 0.8× 12 364
Mostafa M. Elshafey Egypt 10 179 1.1× 24 0.2× 70 0.8× 34 0.9× 44 1.4× 14 450
Zihua Xuan China 10 118 0.7× 30 0.2× 53 0.6× 32 0.8× 19 0.6× 30 287

Countries citing papers authored by Xinlu Fu

Since Specialization
Citations

This map shows the geographic impact of Xinlu Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinlu Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinlu Fu more than expected).

Fields of papers citing papers by Xinlu Fu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinlu Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinlu Fu. The network helps show where Xinlu Fu may publish in the future.

Co-authorship network of co-authors of Xinlu Fu

This figure shows the co-authorship network connecting the top 25 collaborators of Xinlu Fu. A scholar is included among the top collaborators of Xinlu Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinlu Fu. Xinlu Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Sun, Pan, et al.. (2024). Diminished retinal microcirculation in mild preeclampsia without obvious retinopathy in high-altitude native Tibetans by OCTA. Photodiagnosis and Photodynamic Therapy. 50. 104396–104396. 1 indexed citations
2.
Li, Xinghui, Haiping Wang, Yandi Wu, et al.. (2023). A novel mouse model of PEDF-associated serious liver inflammation, hepatic tumorigenesis and cardiovascular injury mimics human nonalcoholic steatohepatitis. Genes & Diseases. 11(1). 11–14. 3 indexed citations
3.
Wu, Yandi, Xinghui Li, Haiping Wang, et al.. (2023). Retinol dehydrogenase 10 reduction mediated retinol metabolism disorder promotes diabetic cardiomyopathy in male mice. Nature Communications. 14(1). 1181–1181. 35 indexed citations
4.
Li, Yuanlong, Ming Yang, Jing Tan, et al.. (2022). Targeting ACSL1 promotes cardiomyocyte proliferation and cardiac regeneration. Life Sciences. 294. 120371–120371. 26 indexed citations
6.
Wang, Kun, Xinlu Fu, Pengjun Zhou, et al.. (2017). Hsp90 inhibitor induces KG-1a cell differentiation and apoptosis via Akt/NF-κB signaling. Oncology Reports. 38(3). 1517–1524. 10 indexed citations
7.
Wang, Wenwen, et al.. (2016). Inhibition of glycogen synthase kinase 3beta ameliorates triptolide-induced acute cardiac injury by desensitizing mitochondrial permeability transition. Toxicology and Applied Pharmacology. 313. 195–203. 24 indexed citations
8.
Zhao, Zhongxiang, Jia Li, Xinlu Fu, et al.. (2016). Tanshinone IIA protects against acetaminophen-induced hepatotoxicity via activating the Nrf2 pathway. Phytomedicine. 23(6). 589–596. 72 indexed citations
9.
Deng, Yuanyuan, Xiaoyan Tan, Gaofeng Chen, et al.. (2016). The <i>in vivo</i> Pig-a gene mutation assay is applied to study the genotoxicity of procarbazine hydrochloride in Sprague-Dawley rats. Fundamental Toxicological Sciences. 3(4). 167–175. 2 indexed citations
10.
Jin, Jing, Zhongxiang Zhao, Wenwen Wang, et al.. (2015). Activation of the farnesoid X receptor attenuates triptolide-induced liver toxicity. Phytomedicine. 22(10). 894–901. 42 indexed citations
11.
Chen, Xi, Zhouhua Wang, Jie Zhou, et al.. (2014). Renal interstitial fibrosis induced by high-dose mesoporous silica nanoparticles via the NF-&kappa;B signaling pathway. International Journal of Nanomedicine. 10. 1–1. 64 indexed citations
12.
Li, Jia, Feihai Shen, Wenwen Wang, et al.. (2014). Activation of Nrf2 Protects against Triptolide-Induced Hepatotoxicity. PLoS ONE. 9(7). e100685–e100685. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026